Jerry Greenfield
St Vincent's Hospital, NSW, Australia
- This delegate is presenting an abstract at this event.
 
      
        Professor Jerry Greenfield is Head, Department of Endocrinology, and Director, Diabetes Services, St Vincent's Hospital (Sydney).  He undertook a PhD at the Garvan Institute (2001-2004) and a post-doctoral fellowship at the University of Cambridge, Addenbrooke’s Hospital, United Kingdom (2005-2006).  His other current positions and roles include: Professor of Medicine, University of NSW; Clinical Associate Dean, St Vincent’s Clinical School, University of NSW; Laboratory Head, Clinical Diabetes, Appetite and Metabolism, Diabetes and Metabolism Division, Garvan Institute; Editor-in-Chief, Endocrinology, Diabetes and Metabolism Case Reports and Editorial Board member, Clinical Obesity. His recent interests focus on elucidating the molecular basis of insulin resistance by studying humans with insulin-sensitive obesity.  He oversees a precision medicine program aimed at determining the ‘omic’ factors that predict maximal effectiveness and safety of diabetes medications in an individual.      
      Presentations this author is a contributor to:
                  
          
          Diabetes health-service delivery: The experiences of young adults with Type 1 diabetes. (#355)
  
  2:00 PM
      
    Janice Wiley    
  
          
            
            ADS Clinical Poster Discussions          
        
                        
          
          Diabetes education: the experiences of young adults with Type 1 diabetes (#356)
  
  2:00 PM
      
    Janice Wiley    
  
          
            
            ADS Clinical Poster Discussions          
        
                        
          
          Genetic susceptibility to type 2 diabetes influences the impact of obesity on heart rate variability (#316)
  
  1:00 PM
      
    Arthur B Jenkins    
  
          
            
            ADS Clinical Poster Viewing          
        
                        
          
          What really happens when patients with Type 2 diabetes (T2DM) are commenced on insulin –longitudinal changes in HbA1c from initiation to 4 years - from the Australian S4S-DINGO – Diabetes Informatics Group (#79)
  
  4:15 PM
      
    David M Hoffman    
  
          
            
            ADS Clinical Orals - Therapies          
        
                        
          
          Case series: the effect of bariatric surgery on glycaemic control in patients with type 1 diabetes mellitus (#336)
  
  1:00 PM
      
    Alice Tang    
  
          
            
            ADS Clinical Poster Viewing          
        
                        
          
          DIABETES OUTREACH CLINIC FOR THE HOMELESS: A MODEL FOR IMPROVED CARE AND OUTCOMES? (#101)
  
  9:45 AM
      
    Alexander Viardot    
  
          
            
            ADS Clinical Orals - Complications / Health Care          
        
                        
          
          The Effect of Specialist Referral on HbA1c: Data from the Australian S4S-DINGO – Diabetes Informatics Group (#362)
  
  2:00 PM
      
    Teresa Lam    
  
          
            
            ADS Clinical Poster Discussions          
        
                        
          
          Measurement of insulin secretion in humans (#30)
  
  12:00 PM
      
    Jerry R Greenfield    
  
          
            
            ADS Basic Symposium - Techniques to Measure Insulin Resistance and Secretion Mice and Men